ITEMS IN AFP WITH KEYWORD:

Attention Deficit/Hyperactivity Disorder

Mar 15, 2011 Issue
ICSI Releases Guideline on Diagnosis and Management of ADHD in Children [Practice Guidelines]

Attention-deficit/hyperactivity disorder (ADHD) is a common condition marked by inattention, hyperactivity, and impulsivity. The Institute for Clinical Systems Improvement (ICSI) has released guideline on diagnosis and management of ADHD in children.


Feb 15, 2011 Issue
Guanfacine (Intuniv) for Attention-Deficit/Hyperactivity Disorder [STEPS]

Guanfacine is an effective short-term treatment option for ADHD in children six to 12 years of age. Sedation is a marked problem in many children. Patients should take the medication daily to avoid adverse effects that occur with abrupt discontinuation or when the guanfacine is restarted.


May 15, 2009 Issue
AAP Responds to AHA Guidelines on Cardiovascular Monitoring Before Starting Stimulants for ADHD [Practice Guidelines]

A recent guideline from the American Heart Association (AHA) recommended routine electrocardiography (ECG) in children before they begin pharmacotherapy for attention-deficit/hyperactivity disorder (ADHD). That recommendation contradicts evidence-based recommendations from the American Academy of Ch...


May 15, 2009 Issue
Stimulants, ADHD, and the Heart [Editorials]


Apr 15, 2009 Issue
Multimodal Treatment of Attention-Deficit/Hyperactivity Disorder in Children [Editorials]


Apr 15, 2009 Issue
Current Strategies in the Diagnosis and Treatment of Childhood Attention-Deficit/Hyperactivity Disorder [Article]

Symptoms of childhood attention-deficit/hyperactivity disorder affect cognitive, academic, behavioral, emotional, social, and developmental functioning. Attention-deficit/hyperactivity disorder is the most commonly diagnosed neurodevelopmental disorder in children and adolescents. An estimated 2 to ...


Feb 15, 2006 Issue
CDC Releases Data on ADHD Diagnosis and Treatment in Children [Practice Guidelines]

A report analyzing the rate of diagnosis and treatment of attention-deficit/hyperactivity disorder (ADHD) among children and adolescents has been released by the Centers for Disease Control and Prevention (CDC).


Nov 1, 2003 Issue
Atomoxetine for ADHD [STEPS]

Atomoxetine is more effective than placebo for treating symptoms of ADHD in children and adults, based on short-term studies. Given safety concerns (growth retardation, potential adverse effects in slow metabolizers) and its high cost, atomoxetine should be considered only as an alternative for pati...


Feb 15, 2002 Issue
AAP Guidelines on Treatment of Children with ADHD [Practice Guidelines]

The American Academy of Pediatrics (AAP) has issued a new guideline for the treatment of school-aged children (six to 12 years) with attention-deficit/hyperactivity disorder (ADHD).


Oct 15, 2001 Issue
Attention-Deficit/Hyperactivity Disorder: Management [Article]

Attention-deficit/hyperactivity disorder (ADHD) is the most common psychiatric disorder of childhood and often persists into adulthood. ADHD is a neurophysiologic disorder defined in behavioral terms and associated with significant morbidity in the realms of social and academic success, and self-est...


Pages: Previous 1 2 3 Next


Email Alerts

Don't miss a single issue. Sign up for the free AFP email table of contents.

Sign Up Now